Stay updated on Viagenpumatucel-L Combo Therapy in NSCLC Clinical Trial
Sign up to get notified when there's something new on the Viagenpumatucel-L Combo Therapy in NSCLC Clinical Trial page.

Latest updates to the Viagenpumatucel-L Combo Therapy in NSCLC Clinical Trial page
- Check5 days agoChange DetectedRecruitment has been closed on this study page, indicating that enrollment is no longer being sought. New help sections have been added to guide readers on how to interpret the study record and how to join a study, and the page’s revision tag has been updated to v3.6.0 with a minor heading formatting adjustment to Intervention/Treatment.SummaryDifference0.4%

- Check12 days agoChange DetectedRevision updated from v3.5.4 to v3.5.5, indicating a minor update to the page's system or template rather than the study data.SummaryDifference0.0%

- Check19 days agoNo Change Detected
- Check26 days agoNo Change Detected
- Check33 days agoChange DetectedThe page now shows Revision: v3.5.4, indicating a newer build of the study entry.SummaryDifference0.0%

- Check48 days agoChange DetectedThe page's revision history now shows Revision: v3.5.3, replacing the previous Revision: v3.5.2.SummaryDifference0.0%

- Check62 days agoChange DetectedRevision: v3.5.2 is now listed, replacing the previous v3.5.0 entry. This reflects a minor software version update.SummaryDifference0.0%

- Check91 days agoChange DetectedRevision updated from v3.4.3 to v3.5.0; no study content or user-facing information was changed.SummaryDifference0.0%

Stay in the know with updates to Viagenpumatucel-L Combo Therapy in NSCLC Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Viagenpumatucel-L Combo Therapy in NSCLC Clinical Trial page.